Projects funded by the NCN
DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy
2020/37/B/NZ7/00422
Keywords:
DNA polymerase θ synthetic lethaility solid tumors precision medicine inhibitors of the DNA double-strand breaks repair proteins
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 19 - announced on 2020-03-16
Amount awarded: 1 614 000 PLN
Project start date (Y-m-d): 2021-02-05
Project end date (Y-m-d): 2024-02-04
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.